How HPV Leads to Cancer, and How Often

Does HPV cause cancer?

Yes. Human papillomavirus (HPV) is the cause of nearly all cervical cancer and a meaningful share of several other cancers. But the part that gets lost in the fear is this: only certain high-risk types cause cancer, and only when the infection persists for years rather than clearing. HPV is the most common sexually transmitted infection in the United States, and the great majority of infections are cleared by the immune system without ever causing harm 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).That HPV is the most common STI in the U.S., that most infections clear on their own within about one to two years, and that persistent high-risk-type infection can progress to cancer..

So having HPV and being at risk for cancer are not the same thing. Nearly everyone who is sexually active will be exposed to HPV at some point, yet only a small fraction of those infections ever progress toward cancer. The virus is common; the cancer outcome is not.

That distinction is the difference between the panic a positive result can trigger and the reality of what it usually means. A diagnosis of HPV is, for most people, a temporary and unremarkable event — not the opening scene of a cancer story. Holding onto that difference is the point of everything that follows on this page.

Which cancers does HPV cause?

HPV causes six kinds of cancer. In the United States it is behind most cervical cancers and many cancers of the anus, the throat (specifically the oropharynx — the back of the tongue and the tonsils), the penis, the vagina, and the vulva. Together these come to roughly 39,300 HPV-associated cancers each year in the U.S. 2Ref 2Centers for Disease Control and Prevention (2024).Basic Information about HPV and Cancer.That HPV causes most cervical cancers plus cancers of the anus, throat/oropharynx, penis, vagina, and vulva; that it causes roughly 39,300 cancers per year in the U.S.; and that cervical cancer is the most common HPV-associated cancer in women while oropharyngeal cancer is the most common (and rising) in men..

About 39,300 HPV-associated cancers are diagnosed in the U.S. each year 2Ref 2Centers for Disease Control and Prevention (2024).Basic Information about HPV and Cancer.That HPV causes most cervical cancers plus cancers of the anus, throat/oropharynx, penis, vagina, and vulva; that it causes roughly 39,300 cancers per year in the U.S.; and that cervical cancer is the most common HPV-associated cancer in women while oropharyngeal cancer is the most common (and rising) in men..

The pattern differs by sex. Cervical cancer is the most common HPV-associated cancer in women. Oropharyngeal (throat) cancer is the most common in men, and it has been rising for years 2Ref 2Centers for Disease Control and Prevention (2024).Basic Information about HPV and Cancer.That HPV causes most cervical cancers plus cancers of the anus, throat/oropharynx, penis, vagina, and vulva; that it causes roughly 39,300 cancers per year in the U.S.; and that cervical cancer is the most common HPV-associated cancer in women while oropharyngeal cancer is the most common (and rising) in men.. The link between HPV and cervical cancer is the strongest and best understood of these, which is why so much prevention and screening is built around the cervix — but it is not the whole story, and treating HPV as a cervical-only concern misses the cancers it causes elsewhere.

Each of these begins the same way — with an infection most people would clear — and becomes a cancer only in the minority where the virus lingers for years.

How does a virus turn into cancer?

It happens slowly, and only when the infection refuses to clear. HPV infects the thin surface cells of the cervix, throat, or anus. In most people the immune system clears the virus within about one to two years and nothing further happens. When a high-risk type lingers instead, it can switch on changes in those cells that, over years to decades, may progress from mild abnormalities to precancer and, in a minority of cases, to cancer 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).That HPV is the most common STI in the U.S., that most infections clear on their own within about one to two years, and that persistent high-risk-type infection can progress to cancer..

Not all HPV is the same. The dozens of HPV types split into high-risk types, which can cause cancer, and low-risk types, which cause genital warts but not cancer. Sorting out high-risk and low-risk HPV is what determines who needs closer follow-up. Cervical screening is designed around exactly this: it looks for the high-risk types and the early cell changes they cause, long before any of it could become cancer.

Understanding how HPV causes cervical cancer also explains the timeline, and the timeline is the good news. Because the process is gradual, there is usually a wide window in which precancerous changes can be found and treated before a true cancer ever develops. That slow march from infection to cell change to precancer is exactly what screening interrupts — which is what makes cervical cancer one of the most preventable cancers there is.

Why most HPV infections never become cancer

Because the immune system usually wins. For most people an HPV infection is temporary — the body clears it within roughly one to two years, often before it ever causes a change anyone could detect 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).That HPV is the most common STI in the U.S., that most infections clear on their own within about one to two years, and that persistent high-risk-type infection can progress to cancer.. This natural HPV clearance is the rule, not the exception. Cancer only becomes a real possibility when a high-risk infection persists for many years and goes unnoticed.

That is also why a single positive HPV test is not a reason to panic. It does not mean cancer, and it does not even mean an infection that will last; most are cleared. What raises risk is not catching HPV once but carrying the same high-risk type, unnoticed, for a long time — which is precisely the situation routine screening is designed to catch early.

Screening does carry a genuine trade-off, though, and it is worth naming honestly. It can detect cell changes — and occasionally cancers — that would never have progressed or caused harm in a person's lifetime. Researchers call this overdiagnosis, and it is a recognized downside of cancer screening, because it can lead to treatment someone never actually needed 3Ref 3Welch HG, Black WC (2010).Overdiagnosis in cancer.The definition of overdiagnosis as a screening harm — the detection of a cancer (or precancerous change) that would never have caused symptoms or death, leading to unnecessary treatment.. That is not a reason to avoid screening; it is a reason to understand that an abnormal result is the start of a conversation, not a verdict.

What a positive HPV test actually means

A positive HPV test means the virus was detected — nothing more, and specifically not that you have cancer or ever will. Because most HPV infections clear on their own, a positive result most often reflects a common, temporary infection the immune system is likely to resolve 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).That HPV is the most common STI in the U.S., that most infections clear on their own within about one to two years, and that persistent high-risk-type infection can progress to cancer.. It is a reason for appropriate follow-up, not a diagnosis of disease.

What happens next depends on the result. A positive high-risk HPV test, sometimes paired with a Pap that looks at the cells themselves, tells a clinician to watch more closely — often by repeating the test later to see whether the infection clears, or by looking directly at the cervix if the cells show changes. The purpose is to catch the rare persistent infection early, while any changes are still precancerous and simple to treat.

The emotional part is worth naming: a positive HPV result can feel like a verdict, and it is not one. It cannot tell you who you got it from or when, because infections can stay silent for years. For most people, the honest reading of a positive test is a common infection with sensible follow-up — not cancer on the way.

How would you even know? Symptoms, screening, and testing

You usually would not know from how you feel. HPV almost never causes symptoms, which is precisely why it spreads so widely and why screening exists at all. When HPV does cause visible signs, they are genital warts — caused by low-risk types that do not lead to cancer. If you are hunting for HPV symptoms as a way to gauge your cancer risk, there is essentially nothing to see; high-risk infection is silent.

That silence is the reason cervical cancer screening works. A Pap test or HPV test looks for the early cell changes and the high-risk types before any symptom appears, so they can be watched or treated. It is one of the few cancers with a reliable early-detection test, and it is the main reason cervical cancer has become far less common where screening is routine. The screening does the job the symptoms cannot.

The safety net is uneven, though. There is no routine HPV test approved for men, and no general screening test for the throat, anal, or penile cancers HPV can cause. HPV testing in men is not part of standard care, which is a large part of why prevention — rather than detection — carries more of the weight for cancers outside the cervix. For those cancers, there is no equivalent of the Pap test standing guard.

Why HPV throat cancer is rising

One HPV-related cancer has been moving in the wrong direction: oropharyngeal cancer, which affects the back of the throat, the base of the tongue, and the tonsils. It is now the most common HPV-associated cancer in men, and its numbers have been climbing for years 2Ref 2Centers for Disease Control and Prevention (2024).Basic Information about HPV and Cancer.That HPV causes most cervical cancers plus cancers of the anus, throat/oropharynx, penis, vagina, and vulva; that it causes roughly 39,300 cancers per year in the U.S.; and that cervical cancer is the most common HPV-associated cancer in women while oropharyngeal cancer is the most common (and rising) in men.. This is the part of the HPV story that gets the least attention, precisely because people associate the virus almost entirely with the cervix.

The difficulty is that there is no routine screening test for throat cancer the way there is for the cervix. Nothing is recommended for the general population to catch it early, so it is often found only once it causes a symptom — a lump in the neck, a persistent sore throat, trouble swallowing, or a voice change that lasts more than a couple of weeks. That absence of an early-detection safety net is one of the strongest arguments for prevention.

It also reframes who HPV cancer is a concern for. Because oropharyngeal cancer skews toward men, and because there is no male equivalent of cervical screening, the cancers HPV causes are not solely a women's health issue. Prevention through vaccination carries more of the weight here, since detection cannot be relied on to catch these cancers early 2Ref 2Centers for Disease Control and Prevention (2024).Basic Information about HPV and Cancer.That HPV causes most cervical cancers plus cancers of the anus, throat/oropharynx, penis, vagina, and vulva; that it causes roughly 39,300 cancers per year in the U.S.; and that cervical cancer is the most common HPV-associated cancer in women while oropharyngeal cancer is the most common (and rising) in men..

What actually lowers the risk?

Two things do most of the work: vaccination and screening. The HPV vaccine protects against the types responsible for most HPV-associated cancers, and it works best when given before any exposure to the virus. U.S. guidelines recommend routine vaccination at ages 11-12, and it can start as early as age 9; catch-up vaccination is recommended through age 26. Some adults aged 27 to 45 who were not vaccinated earlier may still benefit, based on a shared decision with their clinician 4Ref 4Centers for Disease Control and Prevention (Advisory Committee on Immunization Practices) (2024).ACIP Recommendations: Human Papillomavirus (HPV) Vaccine.The U.S. HPV vaccination recommendation: routine at ages 11-12 (starting as early as 9), catch-up through age 26, and shared clinical decision-making for some adults 27-45..

The vaccine prevents cancer-causing infections best when given before exposure — which is why it is recommended in early adolescence 4Ref 4Centers for Disease Control and Prevention (Advisory Committee on Immunization Practices) (2024).ACIP Recommendations: Human Papillomavirus (HPV) Vaccine.The U.S. HPV vaccination recommendation: routine at ages 11-12 (starting as early as 9), catch-up through age 26, and shared clinical decision-making for some adults 27-45..

Condoms help but do not finish the job. Consistent, correct condom use lowers the risk of HPV, yet it offers only partial protection, because HPV spreads through skin-to-skin contact of genital areas a condom does not cover 5Ref 5Centers for Disease Control and Prevention (2024).Condom Use: An Overview.That consistent, correct condom use provides only partial protection against HPV because HPV spreads by skin-to-skin contact of areas a condom does not cover.. For the cancer-causing types, vaccination is the most reliable protection, and condoms add to it rather than replace it.

The two strategies cover different gaps. Vaccination prevents the infection in the first place; screening catches the rare persistent infection before it can become cancer in the one place — the cervix — where an effective test exists. Staying current with cervical screening closes the loop for those who have a cervix, and vaccination protects the sites where no screening test stands guard. Together they are why HPV-associated cancer is, for most people, a largely preventable outcome rather than an inevitable one.